Skip to content

Omeros OMER Market capitalization

Market capitalization at other companies

Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$860.08M+94.2%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$2.06B+1,531%
Immunome logo
ImmunomeIMNM
$2.47B+323%
Vor Biopharma logo
Vor BiopharmaVOR
$871.44M+873%
Annexon logo
AnnexonANNX
$825.77M+290%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$2.71B+226%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
P/S8.5×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Computed from the period-end share price: $748.71M.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's market capitalization?
Omeros (OMER) reported market capitalization of $748.71M in Q1 2026.
How has Omeros's market capitalization changed year-over-year?
Omeros's market capitalization increased by 57.2% year-over-year, from $476.35M to $748.71M.
What is the long-term trend for Omeros's market capitalization?
Over 5 years (2020 to 2025), Omeros's market capitalization has grown at a 6.6% compound annual growth rate (CAGR), from $884.96M to $1.22B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.